A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)

NCT00642460 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Idiopathic Arthritis

Interventions

DRUG: tocilizumab [RoActemra/Actemra]
DRUG: Placebo
DRUG: Non-steroidal anti-inflammatory drugs (NSAIDs)
DRUG: methotrexate
DRUG: corticosteroids

Sponsor

Hoffmann-La Roche